Cerebral venous and sinus thrombosis and thrombophilic mutations in western Iran: Association with factor v Leiden

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 4, 2010, Pages 430-434

  Rahimi, Zohreh ^a,b   Mozafari, Hadi ^a   Bigvand, Amir Hossein Amiri ^a   Doulabi, Reza Mohammad ^a   Vaisi Raygani, Asad ^b   Afshari, Dariush ^b   Razazian, Nazanin ^b   Rezaei, Mansour ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CVST; factor V Leiden; MTHFR C677T; prothrombin G20210A; Western Iran

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; HINF I ENZYME; MNL 1 ENZYME; PROTHROMBIN; RESTRICTION ENDONUCLEASE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBRAL VENOUS AND SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL THROMBOSIS; IRAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PREVALENCE; PROTHROMBIN; SINUS THROMBOSIS, INTRACRANIAL; THROMBOPHILIA;

EID: 77954901320     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609335519     Document Type: Article

References (21)

1. Endler G., Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 2003 ; 330 (1-2). 31-55.
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 ; 88 (10). 3698-3703.
3. Kimber J. Cerebral venous sinus thrombosis. Q J Med. 2002 ; 95 (3). 137-142.
4. Saadatnia M., Tajmirriahi M. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand. 2007 ; 115 (5). 295-300.
5. Otrock ZK, Taher AT, Shamseddeen WA, Mahfouz RA Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis. J Thromb Thrombolysis. 2008 ; 26 (1). 41-43.
6. Rahimi Z., Vaisi-Raygani A., Mozafari H., Kharrazi H., Rezaei M., Nagel RL Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis. 2008 ; 25 (3). 280-283.
7. Old JM, Higgs DR Gene analysis. In: Weatherall DJ, ed. Methods in Hemotology. The Thalassemias. Vol 6., London: Churchill Livingstone ; 1983: 74-101.
8. Bertina RM, Koeleman BPC, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 ; 369 (6475). 64-67.
9. Frosst P., Blom HJ, Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 ; 10 (1). 111-113.
10. Dölek B., Eraslan S., Eroǧlu S., et al. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Clin Appl Thromb Hemost. 2007 ; 13 (4). 435-438.
11. Gadelha T., Andre Ch, Juca AAV, Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis. 2005 ; 19 (1). 49-52.
12. Ludemann P., Nabavi D., Junker R., et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998 ; 29 (12). 2507-2510. (Pubitemid 28543998)
13. Lichy CH, Dong-Si T., Reuner K., et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol. 2006 ; 253 (3). 316-320.
14. Dentali F., Crowther M., Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006 ; 107 (7). 2766-2773.
15. Buyru N., Altinisik J., Somay G., Ulutin T. Factor V Leiden mutation in cerebrovascular disease. Clin Appl Thromb Hemost. 2005 ; 11 (3). 339-342.
16. Rodrigues CA, Rocha LKA, Morelli VM, Franco RF, Lourenco DM Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost. 2004 ; 2 (7). 1211-1212.
17. Bezemer ID, Doggen CJM, Vos HL, Rosendaal FR no association between the common MTHFR 677Cĝ†'T polymorphism and venous thrombosis. Arch Intern Med. 2007 ; 167 (5). 497-501.
18. den Heijer M., Koster T., Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996 ; 334 (12). 759-762. (Pubitemid 26089357)
19. Okumus G., Kiyan E., Arseven O., et al. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost. 2008 ; 14 (2). 168-173.
20. Saadatnia M., Mousavi SA, Haghighi S., Aminorroaya A. Cerebral vein and sinus thrombosis in Isfahan-Iran: a changing profile. Can J Neurol Sci. 2004 ; 31 (4). 474-477.
21. Janghorbani M., Zare M., Saadatnia M., Mousavi SA, Mojarrad M., Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand. 2008 ; 117 (2). 117-121.